Rolling Open Call for Proposals

Founded in 2015, BioCanRx (Biotherapeutics for Cancer Treatment) is a not-for-profit organization with a mission to improve outcomes for cancer patients by accelerating the development of cost-effective and curative biotherapies. BioCanRx was awarded seed funding of $25 million from the federal government’s Networks of Centres of Excellence (NCE) Program, and has attracted additional tens of millions from partners in all sectors of the economy.

BioCanRx supports biotherapeutic development research through four research programs and a number of core facilities that are accessible to all members of the BioCanRx network. Three of the research programs (Catalyst Projects, Enabling Studies, Clinical Trials) are designed to reflect the translational focus of BioCanRx, which organizes its investments into a pipeline-like structure common to the biotechnology industry. The fourth program (Clinical, Social, and Economic Impact Program) funds research into issues of scientific methodology, clinical trial design, patient engagement, health economics and commercial viability of BioCanRx biotherapeutic platforms and technologies. All research programs are targeted toward applicants who have already made substantial advances in their basic research programs and are now ready to work in collaborative, multidisciplinary, academic–industry teams to move their discoveries into the clinic in a rational, scientifically well-supported and highly disciplined fashion. 

Apply when you are ready

BioCanRx is using a rolling, open call that allows research teams to submit proposals to any of our research programs at any time.